|
|
|
|
Antares Pharma reports positive results from Phase II contraceptive gel trial
(Datamonitor via COMTEX) Antares Pharma and the Population Council have announced positive results from a dose-finding Phase II trial for a contraceptive gel containing the progestin Nestorone and estradiol, utilizing the Antares advanced transdermal delivery...
|
|
|
Antares Pharma reports positive results from Phase II contracepti...
Company: Antares Pharma, Inc.(AIS) Antares Pharma and the Population Council have announced positive results from a dose-finding Phase II trial for a contraceptive gel containing the progestin Nestorone and estradiol, utilizing the Antares advanced...
|
|
|
Antares Pharma And Population Council Announce Positive Phase 2 Trial Results
Antares Pharma, Inc.(NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive gel containing the progestin Nestorone and estradiol (NES/E2) utilizing the Antares ATD (advanced...
|
|
|
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
Clinical Trials Update Breaking News News source: Business Wire Antares Pharma, Inc.(NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive gel containing the progestin...
|
|
|
Antares Pharma, Population Council report positive Phase 2 results for novel NES/E2 contraceptive gel
Antares Pharma, Inc.(NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive gel containing the progestin Nestorone and estradiol (NES/E2) utilizing the Antares ATD (advanced...
|
|
|
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
EWING, N.J.& NEW YORK-- (BUSINESS WIRE) -- (NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive gel containing the progestin Nestorone and estradiol (NES/E2) utilizing...
|
|
|
Antares Pharma And Population Council Announce Positive Phase 2 Trial Results
First Transdermal Contraceptive ATD Gel Contains Nestorone EWING, NJ, AND NEW YORK, NY (January 11, 2010) - Antares Pharma, Inc.(NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel...
|
|
|
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
First Transdermal Contraceptive ATD?Gel Contains Nestorone EWING, N.J? & NEW YORK( WIRE) Antares Pharma, Inc. (NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive...
|
|
|
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
GA_googleFillSlot("Press336"); GA_googleFillSlot("Press160"); EWING, N.J.& NEW YORK - (Business Wire) Antares Pharma, Inc. (NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel...
|
|
|
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
EWING, N.J.& NEW YORK--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE This first of its kind contraceptive gel may offer an attractive option for women. The combination of Nestorone, a highly potent and versatile synthetic progestin, and the natural...
|
|
|
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
GA_googleFillSlot("Press336"); GA_googleFillSlot("Press160"); EWING, N.J.& NEW YORK - (Business Wire) Antares Pharma, Inc. (NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel...
|
|
|
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
First Transdermal Contraceptive ATD" Gel Contains Nestorone EWING, N.J.& NEW YORK--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel...
|
|
|
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
Antares Pharma, Inc.(NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive gel containing the progestin Nestorone and estradiol (NES/E2) utilizing the Antares ATD (advanced...
|
|
|
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
First Transdermal Contraceptive ATD Gel Contains Nestorone Antares Pharma, Inc.(NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive gel containing the progestin Nestorone...
|
|
|
Antares Pharma and Population Council Announce Positive Phase 2
Antares Pharma Inc (AIS) Stock Quote, Chart, News, Add to Watchlist Antares Pharma, Inc.(NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive gel containing the progestin...
|
|
|
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
EWING, N.J.& NEW YORK - (BUSINESS WIRE) - Antares Pharma, Inc. (NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive gel containing the progestin Nestorone and...
|
|
|
BioSante Pharmaceuticals, Inc. News Release
- BioSante Pharmaceuticals, Inc.(NASDAQ: BPAX) will present at the OneMedForum and Biotech Showcase Conferences in San Francisco. Stephen M. Simes, BioSante's president & CEO, will present at the OneMedForum on Tuesday January 12, 2010 at 11:30 am...
|
|
|
BioSante Pharmaceuticals, Inc. To Present At OneMedForum and Biotech Showcase Conferences
- BioSante Pharmaceuticals, Inc.(NASDAQ: BPAX) will present at the OneMedForum and Biotech Showcase Conferences in San Francisco. Stephen M. Simes, BioSante's president & CEO, will present at the OneMedForum on Tuesday January 12, 2010 at 11:30...
|
|
|
BioSante Pharmaceuticals, Inc. To Present At OneMedForum and Biotech Showcase Conferences
Companies mentioned in this article: BioSante Pharmaceuticals, Inc.LINCOLNSHIRE, Ill. -- (BUSINESS WIRE) -- BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) will present at the OneMedForum and Biotech Showcase Conferences in San Francisco. Stephen M.
|
|
|
BioSante Pharmaceuticals, Inc. To Present At OneMedForum and Biotech Showcase Conferences
LINCOLNSHIRE, Ill.- (Business Wire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) will present at the OneMedForum and Biotech Showcase Conferences in San Francisco. Stephen M. Simes, BioSantes president & CEO, will present at the OneMedForum on...
|
|
|
BioSante Pharmaceuticals, Inc. To Present At OneMedForum and Biotech Showcase Conferences
LINCOLNSHIRE, Ill.- (BUSINESS WIRE) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) will present at the OneMedForum and Biotech Showcase Conferences in San Francisco. Stephen M. Simes, BioSante's president & CEO, will present at the OneMedForum on...
|
|
|
BioSante Pharmaceuticals, Inc. To Present At OneMedForum and Biotech Showcase Conferences
BioSante Pharmaceuticals, Inc.(NASDAQ: BPAX) will present at the OneMedForum and Biotech Showcase Conferences in San Francisco. Stephen M. Simes, BioSante's president&CEO, will present at the OneMedForum on Tuesday January 12, 2010 at 11:30 am PST...
|
|
|
BioSante Pharmaceuticals, Inc. To Present At OneMedForum and Biotech Showcase Conferences
BioSante Pharmaceuticals, Inc.(NASDAQ: BPAX) will present at the OneMedForum and Biotech Showcase Conferences in San Francisco. Stephen M. Simes, BioSantes president & CEO, will present at the OneMedForum on Tuesday January 12, 2010 at 11:30 am PST...
|
|
|
BioSante Pharmaceuticals, Inc. To Present At OneMedForum and Biotech Showcase Conferences
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc.(NASDAQ: BPAX) will present at the OneMedForum and Biotech Showcase Conferences in San Francisco. Stephen M. Simes, BioSantes president & CEO, will present at the OneMedForum on...
|
|
|
BioSante Pharmaceuticals, Inc. To Present At OneMedForum and Biotech Showcase Conferences
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc.(NASDAQ: BPAX - News) will present at the OneMedForum and Biotech Showcase Conferences in San Francisco. Stephen M. Simes, BioSantes president & CEO, will present at the...
|
